Insider · CIK 0001400971
Bradley L Campbell
Files at FOLD (AMICUS THERAPEUTICS, INC.). First filing Nov 4, 2024, latest Mar 4, 2026.
Bradley L Campbell files SEC Form 4 as CEO, president and director at FOLD (AMICUS THERAPEUTICS, INC.). Since Nov 4, 2024, Bradley L Campbell has reported 0 open-market buys worth $0 and 9 open-market sells worth $2.8M, the latest filed on Mar 4, 2026.
A track record needs three past buys with six months of prices behind them; Bradley L Campbell has 0, so none is measured yet.
The newest scored trade: sold $323k of FOLD on Mar 2, 2026, filed Mar 4, 2026, scored 19 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 5 sells worth $2.5M.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 19Weak | AMICUS THERAPEUTICS, INC. | $323k 22,500 shares | -2% | - | |
| 15Weak | AMICUS THERAPEUTICS, INC. | $1.1M 75,000 shares | -7% | - | |
| 21Weak | AMICUS THERAPEUTICS, INC. | $846k 77,926 shares | -6% | - | |
| 16Weak | AMICUS THERAPEUTICS, INC. | $146k 14,587 shares | -1% | - | |
| 16Weak | AMICUS THERAPEUTICS, INC. | $147k 14,587 shares | -1% | - | |
| 0Weak | AMICUS THERAPEUTICS, INC. | $4,000 400 shares | -0% | - | |
| 0Weak | AMICUS THERAPEUTICS, INC. | $75k 7,500 shares | -1% | - | |
| 0Weak | AMICUS THERAPEUTICS, INC. | $99k 7,901 shares | -1% | - | |
| 0Weak | AMICUS THERAPEUTICS, INC. | $86k 7,500 shares | -1% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 2, 2026 | FOLD AMICUS THERAPEUTICS INC | 22,500 0.01% of outstanding | $323k | Mar 2, 2026 | $1.9M |
| Jan 20, 2026 | FOLD AMICUS THERAPEUTICS INC | 75,000 0.02% of outstanding | $1.1M | Jan 20, 2026 | $1.1M |
| Dec 15, 2025 | FOLD AMICUS THERAPEUTICS INC | 77,926 0.03% of outstanding | $822k | Dec 15, 2025 | $293k |
| Dec 1, 2025 | FOLD AMICUS THERAPEUTICS INC | 14,587 0.00% of outstanding | $145k | Dec 1, 2025 | $147k |
| Nov 24, 2025 | FOLD AMICUS THERAPEUTICS INC | 14,587 0.00% of outstanding | $139k | Nov 24, 2025 | none |
| Feb 19, 2025 | FOLD AMICUS THERAPEUTICS INC | 400 0.00% of outstanding | $3,940 | Feb 19, 2025 | $75k |
| Dec 2, 2024 | FOLD AMICUS THERAPEUTICS INC | 7,500 0.00% of outstanding | $75k | Dec 2, 2024 | $352k |
| Nov 6, 2024 | FOLD AMICUS THERAPEUTICS INC | 7,901 0.00% of outstanding | $93k | Nov 6, 2024 | $253k |
| Nov 1, 2024 | FOLD AMICUS THERAPEUTICS INC | 7,500 0.00% of outstanding | $86k | Nov 1, 2024 | $167k |
Transactions
Every row this insider has filed, 43 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Common Stock | -1,008,680 | $14.50 | $15M | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -103,578 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -151,515 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -188,257 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -283,555 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -187,970 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -301,109 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -265,517 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -482,908 | - | - | 0 | Apr 27, 2026 |
| Mar 2, 2026 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -22,500 | $14.35 | $323k | 998,680 | Mar 4, 2026 |
| Jan 20, 2026 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +75,000 | $6.10 | $458k | 1,096,180 | Jan 22, 2026 |
| Jan 20, 2026 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -75,000 | $14.31 | $1.1M | 1,021,180 | Jan 22, 2026 |
| Jan 20, 2026 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Stock Options (right to buy)derivative10b5-1 | -75,000 | $0.00 | $0 | 0 | Jan 22, 2026 |
| Dec 26, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -108,602 | $14.25 | $1.5M | 1,021,180 | Dec 30, 2025 |
| Dec 15, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +70,426 | $9.03 | $636k | 1,207,708 | Dec 17, 2025 |
| Dec 15, 2025 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -77,926 | $10.86 | $846k | 1,129,782 | Dec 17, 2025 |
| Dec 15, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Stock Options (right to buy)derivative10b5-1 | -70,426 | $0.00 | $0 | 0 | Dec 17, 2025 |
| Dec 1, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +14,587 | $9.03 | $132k | 1,151,869 | Dec 3, 2025 |
| Dec 1, 2025 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -14,587 | $10.01 | $146k | 1,137,282 | Dec 3, 2025 |
| Dec 1, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Stock Options (right to buy)derivative10b5-1 | -14,587 | $0.00 | $0 | 70,426 | Dec 3, 2025 |
| Nov 24, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +14,587 | $9.03 | $132k | 1,151,869 | Nov 26, 2025 |
| Nov 24, 2025 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -14,587 | $10.04 | $147k | 1,137,282 | Nov 26, 2025 |
| Nov 24, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Stock Options (right to buy)derivative10b5-1 | -14,587 | $0.00 | $0 | 85,013 | Nov 26, 2025 |
| Mar 15, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -13,375 | $8.90 | $119k | 1,137,282 | Mar 18, 2025 |
| Feb 19, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +400 | $9.03 | $3,612 | 1,151,057 | Feb 21, 2025 |
| Feb 19, 2025 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -400 | $10.00 | $4,000 | 1,150,657 | Feb 21, 2025 |
| Feb 19, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Stock Options (right to buy)derivative10b5-1 | -400 | $0.00 | $0 | 99,600 | Feb 21, 2025 |
| Feb 11, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Common Stock | +137,075 | $0.00 | $0 | 1,220,768 | Feb 13, 2025 |
| Feb 11, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -70,711 | $9.57 | $677k | 1,150,657 | Feb 13, 2025 |
| Jan 2, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -20,647 | $9.31 | $192k | 866,007 | Jan 6, 2025 |
| Jan 3, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Common Stock | +266,528 | $0.00 | $0 | 1,132,535 | Jan 6, 2025 |
| Jan 3, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -41,474 | $9.41 | $390k | 1,091,061 | Jan 6, 2025 |
| Jan 4, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -7,368 | $9.41 | $69k | 1,083,693 | Jan 6, 2025 |
| Jan 3, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Stock Options (right to buy)derivative | +482,908 | $0.00 | $0 | 482,908 | Jan 6, 2025 |
| Dec 2, 2024 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +7,500 | $8.61 | $65k | 894,154 | Dec 3, 2024 |
| Dec 2, 2024 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -7,500 | $10.02 | $75k | 886,654 | Dec 3, 2024 |
| Dec 2, 2024 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Stock Options (right to buy)derivative10b5-1 | -7,500 | $0.00 | $0 | 0 | Dec 3, 2024 |
| Nov 6, 2024 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +7,901 | $12.28 | $97k | 894,555 | Nov 7, 2024 |
| Nov 6, 2024 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -7,901 | $12.50 | $99k | 886,654 | Nov 7, 2024 |
| Nov 6, 2024 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Stock Options (right to buy)derivative10b5-1 | -7,901 | $0.00 | $0 | 67,100 | Nov 7, 2024 |
| Nov 1, 2024 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +7,500 | $8.61 | $65k | 894,154 | Nov 4, 2024 |
| Nov 1, 2024 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -7,500 | $11.46 | $86k | 886,654 | Nov 4, 2024 |
| Nov 1, 2024 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Stock Options (right to buy)derivative10b5-1 | -7,500 | $0.00 | $0 | 7,500 | Nov 4, 2024 |
Questions about Bradley L Campbell
Answered from the filings on this page, as of the latest one.
Is Bradley L Campbell buying or selling?
In the last 12 months Bradley L Campbell reported 0 open-market buys worth $0 and 5 open-market sells worth $2.5M on SEC Form 4; the latest was sold $323k of FOLD on Mar 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Bradley L Campbell's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bradley L Campbell has 0.
Where does Bradley L Campbell file Form 4?
Bradley L Campbell has filed Form 4 at FOLD (AMICUS THERAPEUTICS, INC.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.